Major Scope

  •  Lung Cancer
  •  Colorectal Cancer
  •  Pancreatic Cancer
  •  Breast Cancer
  •  Prostate Cancer
  •  Liver Cancer
  •  Leukemia
  •  Bladder Cancer
  •  Kidney Cancer
  •  Endometrial Cancer
  •  Oncology Case Reports
  •  Radiation Therapy

Abstract

Citation: Clin Oncol. 2022;7(1):1930.DOI: 10.25107/2474-1663-v7-id1930

Persistent Lymphedema in a Patient with Advanced Gastric Cancer with ERBB3 Mutation

Chen Yang, Dongliang Mao, Qianyun He, Chen Wang and Mei Wang

Department of Oncology, Shanghai Jiao Tong University, China
These authors contributed equally to this work

*Correspondance to: Mei Wang 

 PDF  Full Text Case Report | Open Access

Abstract:

Gastric cancer remains a major global health burden with high recurrence and mortality rates, especially in countries in East Asia. Studies have shown that gastric cancer presenting with lymphedema has poor survival. Furthermore, no standard treatment has been accepted for metastatic gastric cancer with lymphedema. In this report, we present a case of advanced gastric cancer with persistent lymphedema after gastrectomy. ERBB3 V104M mutation was identified by next-generation sequencing. The patient did not have a good response to nivolumab-based treatment with pyrotinib plus chemotherapy. Advanced gastric cancer with refractory lymphedema remains a challenge with immunotherapy based treatment.

Keywords:

Gastric cancer; Lymphedema; Nivolumab; ERBB3; Pyrotinib

Cite the Article:

Yang C, Mao D, He Q, Wang C, Wang M. Persistent Lymphedema in a Patient with Advanced Gastric Cancer with ERBB3 Mutation. Clin Oncol. 2022;7:1930..

Journal Basic Info

  • Impact Factor: 3.231**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
  • PubMed NLM ID: 101705590

Search Our Journal

Journal Indexed In

Articles in PubMed

NMR Metabolomics in Ionizing Radiation
 PubMed  PMC  PDF  Full Text
Metastatic Retroperitoneal Paraganglioma: Case Report and Review of the Literature
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Ezrin Intracellular Cytoskeleton Marker is Over Expressed in Pancreatic Ductal Adenocarcinoma: A Prospective Cohort Study
 Abstract  PDF  Full Text
Influence of Hydrocortisone in Chemotherapy and Photodynamic Therapy in HEp-2 Cells
 Abstract  PDF  Full Text
View More...